BMC Neuroscience 2008-01-01

Synergistic effect of CART (cocaine- and amphetamine-regulated transcript) peptide and cholecystokinin on food intake regulation in lean mice.

Lenka Maletínská, Jana Maixnerová, Resha Matysková, Renata Haugvicová, Zdeno Pirník, Alexander Kiss, Blanka Zelezná

文献索引:BMC Neurosci. 9 , 101, (2008)

全文:HTML全文

摘要

CART (cocaine- and amphetamine-regulated transcript) peptide and cholecystokinin (CCK) are neuromodulators involved in feeding behavior. This study is based on previously found synergistic effect of leptin and CCK on food intake and our hypothesis on a co-operation of the CART peptide and CCK in food intake regulation and Fos activation in their common targets, the nucleus tractus solitarii of the brainstem (NTS), the paraventricular nucleus (PVN), and the dorsomedial nucleus (DMH) of the hypothalamus.In fasted C57BL/6 mice, the anorexigenic effect of CART(61-102) in the doses of 0.1 or 0.5 microg/mouse was significantly enhanced by low doses of CCK-8 of 0.4 or 4 microg/kg, while 1 mg/kg dose of CCK-A receptor antagonist devazepide blocked the effect of CART(61-102) on food intake. After simultaneous administration of 0.1 microg/mouse CART(61-102) and of 4 microg/kg of CCK-8, the number of Fos-positive neurons in NTS, PVN, and DMH was significantly higher than after administration of each particular peptide. Besides, CART(61-102) and CCK-8 showed an additive effect on inhibition of the locomotor activity of mice in an open field test.The synergistic and long-lasting effect of the CART peptide and CCK on food intake and their additive effect on Fos immunoreactivity in their common targets suggest a co-operative action of CART peptide and CCK which could be related to synergistic effect of leptin on CCK satiety.


相关化合物

  • L-365260
  • 地伐西匹

相关文献:

Combination pharmacotherapy for the treatment of neuropathic pain in adults.

2012-01-01

[Cochrane Database Syst. Rev. 7 , CD008943, (2012)]

Modeled structure of a G-protein-coupled receptor: the cholecystokinin-1 receptor.

2005-01-13

[J. Med. Chem. 48(1) , 180-91, (2005)]

A cholecystokinin-1 receptor agonist (CCK-8) mediates increased permeability of brain barriers to leptin.

2008-07-01

[Br. J. Pharmacol. 154(5) , 1009-15, (2008)]

Cholecystokinin action on layer 6b neurons in somatosensory cortex.

2009-07-28

[Brain Res. 1282 , 10-9, (2009)]

CCK(B) receptor antagonist L365,260 potentiates the efficacy to and reverses chronic tolerance to electroacupuncture-induced analgesia in mice.

2007-03-15

[Brain Res. Bull. 71(5) , 447-51, (2007)]

更多文献...